• A 27-Year-Old Female With JAK2 Mutation: A Case of Budd-Chiari Syndrome Secondary to Prolonged Oral Contraceptive Pill Use
• A diagnostic dilemma: cytomegalovirus colitis as an uncommon comorbidity in inflammatory bowel disease: a case report
• Acceptance & Commitment Therapy for Adults Living With Inflammatory Bowel Disease & Distress: A Randomized Controlled Trial
• Allostatic load increases the incidence and risk of adverse prognosis in inflammatory bowel disease
• Analysis of risk factors for surgical site infection and other postoperative complications in patients following loop ileostomy reversal
• Assessment of the causal relationship between inflammatory bowel diseases and chronic kidney diseases: A two-sample bidirectional mendelian randomization study among European population
• Association between inflammatory bowel disease and atrial fibrillation: A systematic review and <em>meta</em>-analysis
• Association between nighttime urinary frequency and clinical outcomes in Japanese patients with ulcerative colitis
• Automated spatial omics landscape analysis approach reveals novel tissue architectures in ulcerative colitis
• Bacteroides fragilis in saliva: investigating links with ulcerative colitis
• Bibliometric analysis of the correlation between H. pylori and inflammatory bowel disease
• Bioinformatics analysis of oxidative stress genes in the pathogenesis of ulcerative colitis based on a competing endogenous RNA regulatory network
• Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
• Claudin-2: A marker for a better evaluation of histological mucosal healing in inflammatory bowel diseases
• Clinicopathologic Features of Primary Immunodeficiency Monogenic Disease-related Very Early Onset Inflammatory Bowel Disease: Focus on Gastrointestinal Histologic Features in IFIH1 Mutations
• Clonal Hematopoiesis of Indeterminate Potential in Crohn's Disease and Ulcerative Colitis
• Combining Gut Microbiota Modulation and Enzymatic-Triggered Colonic Delivery by Prebiotic Nanoparticles Improves Mouse Colitis Therapy
• Comparative Efficacy of Biologics and Small Molecule Therapies in Improving Patient-Reported Outcomes in Ulcerative Colitis: Systematic Review and Network Meta-Analysis
• Comprehensive evaluation of disulfidptosis in intestinal immunity and biologic therapy response in Ulcerative Colitis
• Concomitant ulcerative colitis and Usher syndrome in a Pakistani patient: A novel case report
• Construction of chlorogenic acid nanoparticles for effective alleviation of ulcerative colitis
• Crusted plaques on the face
• Deep mucosal healing in ulcerative colitis: how deep is better?
• Determining the Treatment Strategy for Refractory Ulcerative Colitis Using Prostaglandin E-major Urinary Metabolite (PGE-MUM) Measurement
• Diagnostic delay in inflammatory bowel diseases in a German population
• Discerning Endoscopic Severity of Inflammatory Bowel Disease by Scoping the Peripheral Blood Transcriptome
• Efficacy and Safety of Sphingosine 1-Phosphate Receptor Modulators for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
• Efficacy of beclomethasone dipropionate in lowering fecal calprotectin levels in patients with ulcerative colitis in clinical remission and at risk of relapse: The Becalcu randomized, controlled trial
• Emerging role of environmental pollutants in inflammatory bowel disease risk, outcomes and underlying mechanisms
• Epidemiologic Associations Between Inflammatory Bowel Disease and Hodgkin Lymphoma or Multiple Sclerosis
• Epidemiology of pediatric inflammatory bowel disease categorized by age subgroups in Korea
• Equivalent Survivorship of Total Hip Arthroplasty in Patients Who Have Inflammatory Bowel Disease
• ETS1 Deficiency in Macrophages Suppresses Colorectal Cancer Progression by Reducing the F4/80+TIM4+ Macrophage Population
• Evaluating the role of large language models in inflammatory bowel disease patient information
• Evaluating the significance of ECSCR in the diagnosis of ulcerative colitis and drug efficacy assessment
• Exploring the relationship between ulcerative colitis, colorectal cancer, and prostate cancer
• Expression and pathogenesis of insulin-like growth factor-1 and insulin-like growth factor binding protein 3 in a mouse model of ulcerative colitis
• Expression of MAF bZIP transcription factor B protects against ulcerative colitis through the inhibition of the NF-kappaB pathway
• From serum metabolites to the gut: revealing metabolic clues to susceptibility to subtypes of Crohn's disease and ulcerative colitis
• Genetic and causal relationship between chronic gastrointestinal diseases and erectile dysfunction: a Mendelian randomization study
• HLA-DQA1*05 associates with anti-TNF immunogenicity and low adalimumab trough concentrations in inflammatory bowel disease patients from the SERENE UC and CD studies
• Ileal pouch-anal anastomosis and end ileostomy result in equivalent graft survival following liver transplantation for inflammatory bowel disease-primary sclerosing cholangitis
• Impact of Rheumatoid Arthritis on Hospitalized Inflammatory Bowel Disease Patients: Study of Demographics, Clinical Characteristics and Outcomes
• Inflammatory Bowel Disease and Cardiovascular Disease: An Integrative Review With a Focus on the Gut Microbiome
• Leishmania donovani infection mimicking ulcerative colitis in an immuno-competent patient
• Leveraging thiol-functionalized biomucoadhesive hybrid nanoliposome for local therapy of ulcerative colitis
• Lung and Cutaneous Abscesses in a Patient with Ulcerative Colitis: A Case Report and Literature Review
• Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Development and Pilot of a Metadata List and Catalogue in Europe
• Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Lessons Learnt From the MINERVA Project in Europe
• Modern Advanced Therapies for Inflammatory Bowel Diseases: Practical Considerations and Positioning
• Modified Gegen Qinlian Decoction modulated the gut microbiome and bile acid metabolism and restored the function of goblet cells in a mouse model of ulcerative colitis
• Mrgprb2-dependent mast cell activation plays a crucial role in acute colitis
• Nanoparticles encapsulated in <em>Abelmoschus esculentus</em> polysaccharide-based pellets as colon targeting approach
• Network pharmacology and experimental verification revealing valnemulin alleviates DSS-induced ulcerative colitis by inhibiting intestinal senescence
• Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti Integrins
• Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti-interleukins
• Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti-Tumor Necrosis Factors
• Oral aged garlic (Allium sativum) alleviates ulcerative colitis in mice by improving gut homeostasis
• Oral delivery of sodium alginate/chitosan bilayer microgels loaded with Lactobacillus rhamnosus GG for targeted therapy of ulcerative colitis
• Outcomes of patients admitted with acute, severe ulcerative colitis on biologic therapy: a retrospective analysis from a tertiary referral hospital
• Patients' Preference on Advanced Therapy and Follow-Up Procedure for Inflammatory Bowel Disease in Japan: A Web-Based 3A Survey
• Peripheral Blood Eosinophilia at Diagnosis of Inflammatory Bowel Disease Is Associated with Severe Disease Course; A Nationwide Study From the epi-IIRN Cohort
• PLGA microspheres carrying EMSCs-CM for the effective treatment of murine ulcerative colitis
• Practical guidance for managing patients with moderate-to-severe ulcerative colitis using small molecule therapies
• Predicting novel biomarkers for early diagnosis and dynamic severity monitoring of human ulcerative colitis
• Quality of life after colectomy and ileo-jpouch-anal anastomosis in paediatric patients with ulcerative colitis
• Quantification of Cytokine-Induced Cell Death in Human Colonic Organoids Using Live Fluorescence Microscopy
• Rare extraintestinal manifestations of ulcerative colitis treated with dual biologic therapy: A case report
• Real-World Treatment Persistence Among Advanced Therapy-Naive or -Experienced Patients with Ulcerative Colitis Initiated on Ustekinumab or Adalimumab
• Research advance on the interaction between gut microbes and cytokines in inflammatory bowel disease
• Rutin Ameliorates Inflammation and Oxidative Stress in Ulcerative Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway
• Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study
• Sarcopenia Is a Risk Factor for Postoperative Complications Among Older Adults With Inflammatory Bowel Disease
• Self-Compassion in Adolescents and Young Adults With Inflammatory Bowel Disease: Relationship of Self-Compassion to Psychosocial and Physical Outcomes
• Si-Ni-San alleviates intestinal and liver damage in ulcerative colitis mice by regulating cholesterol metabolism
• Small Molecule Therapy for Inflammatory Bowel Disease: JAK Inhibitors and S1PR Modulators
• Spine and sacroiliac joint involvement in newly diagnosed inflammatory bowel disease patients - clinical and magnetic resonance imaging findings from a population-based cohort
• Subcutaneous infliximab cut-off points in patients with inflammatory bowel disease. Data from the ENEIDA registry
• Subcutaneous versus intravenous infliximab therapy - a real-world study: toward higher drug concentrations
• The Challenge of IBD-Related Arthritis Screening Questionnaires in Early and Predominantly Entheseal Phenotypes
• The Composition of the Fecal and Mucosa-adherent Microbiota Varies Based on Age and Disease Activity in Ulcerative Colitis
• The contribution of dietary advanced glycation end-products and genetic risk in the development of inflammatory bowel disease: a prospective cohort study
• The cost of IBD care - how to make it sustainable
• The effects of air and transportation noise pollution-related altered blood gene expression, DNA methylation, and protein abundance levels on gastrointestinal diseases risk
• The emerging role of neutrophil extracellular traps in ulcerative colitis
• The emerging role of the gut microbiota and its application in inflammatory bowel disease
• The relationship among vedolizumab drug concentrations, biomarkers of inflammation, and clinical outcomes in a Canadian real-world study
• Therapeutic effect and mechanism of Ento-PB on ulcerative colitis in BALB/c mice induced by sodium dextran sulfate
• Therapeutic inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease
• Tofacitinib Citrate Coordination-Based Dual-Responsive/Scavenge Nanoplatform Toward Regulate Colonic Inflammatory Microenvironment for Relieving Colitis
• Tofacitinib Does Not Impair Sperm Quality in Men With Ulcerative Colitis
• Tofacitinib in Ulcerative Colitis - Second-Line Therapy, First-Rate Results
• Transanal circumferential pouch advancement for treatment of pouch vaginal fistulae
• Transcriptomic and multi-cytokines profile analysis revealed new insights into the integrating mechanisms of cyanidin-3-O-glucoside on male reproductive damage amelioration
• Treatment Targets Should Influence Choice of Infliximab Dose Intensification Strategy in Inflammatory Bowel Disease: A Pharmacokinetic Simulation Study
• Unplanned 30-Day Readmissions After Hospitalization for Irritable Bowel Syndrome
• US National Estimates of Contemporary Mortality Rates in Patients with Ulcerative Colitis Undergoing Colectomy
• Washed microbiota transplantation improved the level of serum vitamin D in ulcerative colitis
• Whole spinal pneumorrhachis following perforation of the rectum: A case report
• WTAP promotes the progression of ulcerative colitis by silencing the expression of CES2 through m(6)A modification